TrialThe Journal of infectious diseases2013

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect.

Julie E Ledgerwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.